PhDr. Květoslava Matulová
Assistant professor, Department of Pathology
correspondence Address:
Jihlavská 340/20, 625 00 Brno
phone: | +420 532 23 3944 |
---|---|
e‑mail: |
Total number of publications: 27
2024
-
Enhancing the utility of chromosome 6 and 8 testing in uveal melanoma biopsies
Biomedical Papers, year: 2024, DOI
-
ROBUST ACUTE MYELOID LEUKEMIA ENGRAFTMENT IN HUMANIZED SCAFFOLDS USING INJECTABLE BIOMATERIALS AND INTRAVENOUS XENOTRANSPLANTATION
Year: 2024, type: Conference abstract
-
STROMAL CELLS ENGINEERED TO EXPRESS T CELL FACTORS INDUCE ROBUST CLL CELL PROLIFERATION IN VITRO AND IN PDX COTRANSPLANTATIONS ALLOWING THE IDENTIFICATION OF ANTI-PROLIFERATIVE DRUGS
Year: 2024, type: Conference abstract
-
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drug
Leukemia, year: 2024, volume: 38, edition: 8, DOI
2023
-
AML engraftment in humanized ossicles is not governed by biomaterial selection.
Year: 2023, type: Conference abstract
-
Coculture model with CD40L, IL4 and IL21 for study chronic lymphocytic leukemia proliferation.
Year: 2023, type: Conference abstract
-
Molekulární testování karcinomu endometria - analýza prvních zkušeností z klinické praxe
Klinická onkologie, year: 2023, volume: 36, edition: 3, DOI
-
Význam nového prediktivního markeru Schlafen 11 u pacientek s karcinomem ovaria léčených chemoterapií založené na platinovém derivátu – výsledky pilotní analýzy
Klinická onkologie, year: 2023, volume: 36, edition: Suppl 1, DOI
2022
-
2022-RA-1304-ESGO Molecular testing of endometrial carcinoma brings growing opportunity to identify patients with inherited risk of cancer
Year: 2022, type: Conference abstract
-
Can Schlafen 11 Help to Stratify Ovarian Cancer Patients Treated with DNA-Damaging Agents?
Cancers, year: 2022, volume: 14, edition: 10, DOI